Advanced search    

Search: authors:"Alessandra Ferrario"

12 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden

Background Little comparative evidence is available on utilisation of cancer medicines in different countries and its determinants. The aim of this study was to develop a statistical model to test the correlation between utilisation and possible determinants in selected European countries. Methods A sample of 31 medicines for cancer treatment that obtained EU-wide marketing...

Diabetes management in Thailand: a literature review of the burden, costs, and outcomes

Management of diabetes represents an enormous challenge for health systems at every level of development. The latter are tested for their ability to continuously deliver high quality care to patients from the day they are diagnosed throughout their life. In this study, we review the status of diabetes management in Thailand and try to identify the key challenges the country needs...

Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications

Erofile Gripiotis 0 Alessandra Ferrario 0 0 London School of Economics and Political Science , Houghton Street, London WC2A 2AE , UK 1 University of Algiers , Rue Didouche Mourad, Algiers , Algeria

The economic burden of diabetes in India: a review of the literature

Diabetes and its complications are a major cause of morbidity and mortality in India, and the prevalence of type 2 diabetes is on the rise. This calls for an assessment of the economic burden of the disease. To conduct a critical review of the literature on cost of illness studies of diabetes and its complications in India. A comprehensive literature review addressing the study...

Challenges in diabetes management in Indonesia: a literature review

of Indonesia and also a member of The Indonesian Society of Endocrinology. Alessandra Ferrario is a Research Officer in health and pharmaceutical policy within the Medical Technology Research Group

Challenges and opportunities for pharmaceutical pricing and reimbursement policies

Ferrario 2 5 Veronika J Wirtz 3 5 Zaheer-Ud-Din Babar 4 5 0 WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Health Economics Department, Gesundheit Österreich GmbH (Austrian

An in-depth analysis of pharmaceutical regulation in the Republic of Moldova

Regulation of the pharmaceutical system is a crucial, yet often neglected, component in ensuring access to safe and effective medicines. The aim of this study was to provide an in-depth analysis of the existing pharmaceutical regulation, including recent changes, in the Republic of Moldova. Data from field work conducted by the World Health Organization (WHO) together with a...

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

Alessandra Ferrario Veronika J. Wirtz Kees de Joncheere Hanne Bak Pedersen Guillaume Dedet Valérie Paris Aukje K. Mantel-Teeuwisse Zaheer-Ud-Din Babar PPRI Conference 0 WHO Collaborating Centre for ... Department at the World Health Organization; Alessandra Ferrario, Research Officer at the London School of Economics; Panos Kanavos, Reader in International Health Policy in the Social Policy Department and

Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review

With an estimated 74% of all deaths attributable to non-communicable diseases (NCDs) in 2010, NCDs have become a major health priority in Brazil. The objective of the study was to conduct a comprehensive literature review on diabetes in Brazil; specifically: the epidemiology of type 2 diabetes, the availability of national and regional sources of data (particularly in terms of...

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications

Background Managed entry agreements (MEAs) are a set of instruments to facilitate access to new medicines. This study surveyed the implementation of MEAs in Central and Eastern Europe (CEE) where limited comparative information is currently available. Method We conducted a survey on the implementation of MEAs in CEE between January and March 2017. Results Sixteen countries...

Personalizing health care: feasibility and future implications

Considerable variety in how patients respond to treatments, driven by differences in their geno- and/ or phenotypes, calls for a more tailored approach. This is already happening, and will accelerate with developments in personalized medicine. However, its promise has not always translated into improvements in patient care due to the complexities involved. There are also concerns...

Personalizing health care: feasibility and future implications

Considerable variety in how patients respond to treatments, driven by differences in their geno- and/ or phenotypes, calls for a more tailored approach. This is already happening, and will accelerate with developments in personalized medicine. However, its promise has not always translated into improvements in patient care due to the complexities involved. There are also concerns...